We tested urine specimens from 222 patients with serogroup 1 Legionella pneumophila pneumonia in two enzyme-linked immunosorbent assays (ELISAs) which used different monoclonal antibodies (A and B) as detector antibodies. Of 171 specimens which contained enough antigen to be detected in the ELISAs, 169 reacted in only one of the two assays. A total of 25 patients whose infections were acquired in any of three Indianapolis hospitals excreted antigen reactive with monoclonal antibody B, but 18 patients who were treated for infections acquired elsewhere reacted with monoclonal antibody A. The urinary antigen ELISA reactivity patterns correlated with the reactivity patterns of L. pneumophila isolates when a separate panel of seven monoclonal antibodies was used. The isolate patterns, in turn, correlated well with environmental isolate patterns from two of the hospitals with nosocomial cases. We conclude that at least two different epitopes exist on the antigen molecules in urine from patients with serogroup 1 L. pneumophila pneumonia and that the subtyping of urinary antigens can be useful epidemiologically.
Indianapolis hospitals excreted antigen reactive with monoclonal antibody B, but 18 patients who were treated for infections acquired elsewhere reacted with monoclonal antibody A. The urinary antigen ELISA reactivity patterns correlated with the reactivity patterns of L. pneumophila isolates when a separate panel of seven monoclonal antibodies was used. The isolate patterns, in turn, correlated well with environmental isolate patterns from two of the hospitals with nosocomial cases. We conclude that at least two different epitopes exist on the antigen molecules in urine from patients with serogroup 1 L. pneumophila pneumonia and that the subtyping of urinary antigens can be useful epidemiologically.
Most patients with serogroup 1 Legionella pneumophila pneumonia excrete specific antigens which can be detected in immunoassays and used to diagnose the illness (11, 14, 15) . Production of antisera capable of yielding highly sensitive assays has, in our hands, been laborious, requiring immunization of large numbers of rabbits to obtain just a few useful antisera (8) . We therefore have produced and evaluated monoclonal antibodies as replacement reagents in these assays. In the course of studying these antibodies, we found that patients with serogroup 1 L. pneumophila pneumonia excrete at least two distinct types of antigen. In this report, we present these findings.
MATERIALS AND METHODS
Monoclonal antibody A production. Monoclonal antibody A was made at the University of Missouri School of Medicine. Cells from the spleens of NFR/H(H-2q) male mice immunized with legionella F1 antigen from Philadelphia 2 strain L. pneumophila organisms (5) were harvested and teased into single-cell suspensions; erythrocytes were lysed and fused with SP2/0 myeloma cells by a modification of the method described by Goding (4) . Immune spleen cells were combined with the myeloma cells at a ratio of 2.5 to 1, and a 50% polyethylene glycol solution was used as the fusing agent. The fused cells were plated at a concentration of 1 x 105 to 2 x 105 cells per well into individual wells of a 96-well tissue culture plate that contained 103 to 104 unstimulated peritoneal exudate celis as feeder cells. Plates were incubated at 37°C in a C02 incubator and observed at intervals for cell growth. Supernatant fluids were tested by enzymelinked immunosorbent assay (ELISA) in F1-antigen-coated wells, and those wells showing positive reactivity were expanded, cloned by limiting dilution, and frozen in liquid * Corresponding author.
nitrogen for further use. Antibody-producing cells were injected into pristane-primed (NFR/N x BALB/c) F1 mice to generate ascites fluid (2) . Isotype specificity of monoclonal antibody A was determined to be immunoglobulin Gi (IgGl) by ELISA with alkaline phosphatase-labeled anti-mouse IgG and IgM (Cooper Biomedical, Inc., West Chester, Pa.). Monoclonal antibodies were purified from the mouse ascites fluid by high-pressure liquid chromatography with an HPHT column (Bio-Rad Laboratories, Richmond, Calif.). Antibodies were eluted with a 0.01 to 0.35 M phosphate (pH 6.8) gradient. Fractions positive by ELISA were dialyzed against distilled water and lyophilized.
Monoclonal antibody B production. Monoclonal antibody B was made at the Indiana University School of Medicine after studies with monoclonal antibody A revealed that it failed to react with urinary antigens excreted by certain patients with serogroup 1 L. pneumophila pneumonia. BALB/c mice were immunized with a vaccine prepared by autoclaving whole L. pneumophila organisms. The vaccine was prepared as previously described (11) except that it consisted of equal parts Philadelphia 1 and Indiana-S strains of serogroup 1 L. pneumophila. The Indiana-S strain was isolated from a patient with serogroup 1 L. pneumophila pneumonia; the urine from this patient contained high concentrations of serogroup 1 L. pneumophila antigen which failed to react with monoclonal antibody A. Hybridomas were prepared as described above for monoclonal antibody A, screened by ELISA, cloned in soft agar (3) , and tested for antibody activity, and preparations of the hybridoma clone were then injected into the peritoneal cavities of pristaneprimed mice. The resulting monoclonal antibodies, determined by agar gel diffusion (Serotec Mouse Monoclonal Antibody Typing Kit; Bioproducts for Science, Inc., Indianapolis, Ind.) of hybridoma culture supernatant fluid to be IgM, were partially purified from the ascitic fluid by hydroxylapaptite chromatography (16) .
Monoclonal antibody ELISA to detect L. pneumophila urinary antigen. An indirect ELISA with polyclonal rabbit IgG as capture antibody and monoclonal antibody A or B as detector antibody was used to study the patient urine specimens. Microdilution tray wells were coated with 0.1 ml of polyclonal IgG (20 ,ug/ml) from rabbits immunized with the Philadelphia 1 strain of L. pneumophila. This preparation was similar to that used in our previously described immunoassays for L. pneumophila antigen (11, 15) . Next, 5% bovine serum albumin in 0.01 M Tris hydrochloride (pH 7.0) was adsorbed to the well walls to diminish nonspecific binding. Then 0.1 ml of the test urine was added, incubated for 1 h at 37°C, and aspirated. After wells were washed, 0.1 ml of monoclonal antibody A (20 to 50 ,ug/ml) or B (124 ,ug/ ml) was added, incubated for 1 h, and aspirated. After wells were washed, 0.1 ml of rabbit anti-mouse immunoglobulin conjugated to alkaline phosphatase as added for 1 h and then aspirated. Ahter wells were rinsed, 0.1 ml of p-nitrophenylphosphate was added to the wells and incubated for 1 to 2 h, depending on the color development determined visually; developed color was measured spectrophotometrically, as described above. We tested urine from a healthy donor in three wells of each 96-well ELISA tray. The mean optical density at 405 nm (OD405) of these three wells was subtracted from the mean OD405 of the test urine, which was run in duplicate, to yield the final result, the net OD405.
Solid-phase radioimmunoassay for serogroup 1 L. pneumophila antigen. A direct solid-phase radioimmunoassay, which used polyclonal rabbit anti-Philadelphia 1 L. pneumophila IgG as both capture and detector antibodies, was performed as previously described (11) . It was used to quantitate by titration the antigen content of urine specimens.
Monoclonal antibody subgrouping of serogroup 1 L. pneumophila isolates. Isolates of serogroup 1 L. pneumophila from 29 study patients and from two hospitals associated with nosocomial cases were subgrouped under code at Université Laval, Quebec, Quebec, Canada, as previously described (6) .
Patient specimens. Urine specimens from 222 patients with pneumonia and supportive laboratory evidence for L. pneumophila infection were tested. To be included, all specimens must have contained enough L. pneumophila antigen to be detected by solid-phase radioimmunoassay (11 (11) for the radioimmunoassay. We found that the polyclonal radioimmunoassay could detect antigen(s) in urine diluted 4-to 8-fold more than was possible with the monoclonal antibody A ELISA and 8-to 16-fold more than was possible with the monoclonal antibody B ELISA (Table 2) . Thus, it was expected that not all urine specimens positive in the polyclonal radioimmunoassay would be positive in the monoclonal antibody ELISAs.
The 222 urine specimens from patients infected with L. pneumophila were then tested in both monoclonal antibody ELISAs. Table 3 shows the results, with urine specimens listed in order of decreasing urinary antigen content as defined by endpoint titration in the radioimmunoassay. Of the 144 specimens with antigen titers of .1:16 by polyclonal antibody radioimmunoassay, all but 1 were positive in at least one of the two monoclonal antibody ELISAs. Of the 78 specimens with titers below 1:16, 28 yielded positive monoclonal antibody ELISA results. Of the 171 specimens positive in either of the monoclonal antibody ELISAs, 169 were positive in either the A or the B ELISA, but not both; 2 specimens were positive in both ELISAs.
The urinary antigen reactivity patterns in monoclonal ELISAs were then correlated with the sites of acquisition of infection. A total of 10 Indianapolis hospitals contributed 76 of the cases. Of 17 cases diagnosed in hospital 1, all 16 patients with infections acquired in hospital 1 excreted type B antigen; the 1 non-nosocomial case excreted type A antigen. Of the 16 patients with nosocomial infection, 1 excreted both A and B antigen types. Of the 15 cases diagnosed in Indianapolis hospital 2, the 9 nosocomial cases all excreted type B antigen and the 6 non-nosocomial cases excreted type A antigen. Of the 17 cases diagnosed in Indianapolis hospital 3, all 9 nosocomial cases excreted type B antigen and all 8 non-nosocomial cases excreted type A antigen. Of the 27 other cases diagnosed in seven other Indianapolis hospitals, 23 excreted type A antigen exclusively. Most of the urine specimens obtained from cities other than Indianapolis, including samples from both nosocomial and non-nosocomial cases, contained type A antigen (Table 4) . napolis hospital 2 were Bellingham 1 subgroup organisms.
As noted above, all patients with nosocomial pneumonia and detectable antigen who were from these two hospitals excreted type B antigens. All 24 isolates obtained from the potable water supply of hospital 1 were also Bellingham 1 subgroup isolates. In contrast, all three potable-watersupply isolates and all four available nosocomial pneumonia isolates from Indianapolis hospital 3 were Oxford 4032E subgroup organisms. No environmental isolates from hospital 2 were available. DISCUSSION Our original goal in developing the monoclonal antibody ELISAs was to produce diagnostic antigen detection assays which rely on a stable inexhaustible supply of well-characterized immunologic reagents. However, the solid-phase radioimmunoassay based on the use of polyclonal IgG from immunized rabbits detected antigen at concentrations 4-to 16-fold lower than the monoclonal-antibody-dependent assays. Thus, although it remains possible that our original goal can be attained with other monoclonal antibodies, the existing monoclonal antibody ELISAs cannot replace our polyclonal antibody immunoassays.
Nonetheless, the existing monoclonal antibody ELISAs demonstrated the presence of antigenic diversity among the antigens excreted in urine from patients with serogroup 1 L. pneumophila pneumonia. It will be important for this diversity to be taken into account by those attempting to devise monoclonal antibody assays to detect serogroup 1 urinary antigens. Because 99.3% of the 144 specimens with an antigen titer of at least 16 reacted in the monoclonal A or B ELISA, it appears that only two major subgroups of serogroup 1 L. pneumophila urinary antigen exist. Additional subgroups, if they exist, must occur infrequently, since the urine specimens tested in this study came from patients as widely distributed in the United States as California, Vermont, and North Carolina, as well as from four European countries.
Two patients excreted antigens which reacted with both monoclonal antibodies. The possibility that the urine specimens were contaminated with protein-A-bearing Staphylococcus aureus, yielding falsely positive assay results (9), was considered. However, one urine specimen failed to yield positive results in an assay in tubes coated with nonspecific rabbit IgG (data not shown), eliminating this possibility (the other specimen was not tested). It is possible that these patients were infected with several serogroup 1 L. pneumophila subgroups. Joly and Winn (7) described a patient from whose upper and lower lung lobes different subgroup isolates were obtained, and simultaneous infection with two legionella species has also been documented (13) . Alternatively, these patients might have been infected with a single strain of serogroup 1 L. pneumophila that bore constituents containing either epitopes or antigens which react with monoclonal antibodies A and B. If so, such isolates must be rare, occurring only twice in 222 assays. The isolate from the pleural fluid of one of these patients yielded a Bellingham 1-like subgrouping pattern. No isolate was available from the other patient.
The urinary antigens detected by the monoclonal antibody ELISAs could all be detected in a single polyclonal-IgGbased assay. The rabbit which produced the polyclonal IgG used for that assay was immunized only with mulitply passaged Philadelphia 1 L. pneumophila organisms (11), yet its IgG was capable of detecting both A and B urinary antigen subgroups. A possible explanation for this observation is that the Philadelphia 1 strain contains both the A and B epitopes. However, of the four patients we studied who were infected with Philadelphia 1-type strains of L. pneumophila, all three with detectable antigen levels excreted antigen reactive only in the monoclonal antibody A ELISA. It seems doubtful, therefore, that the Philadelphia 1-type organisms contain molecules bearing epitopes which react with monoclonal antibody B. More likely, an epitope distinct from A and B and common to all the subgroup patterns shown in Table 5 exists on either the same or different molecules as the A and B epitopes. This epitope must also be present on urinary antigen and be one of the epitopes recognized by the polyclonal antiserum. The common epitope may be the one recognized by monoclonal antibody 1 of the subgrouping panel originally devised by McKinney et al. (12) , since this monoclonal antibody, which is the same monoclonal antibody 1 used for the subgrouping of our isolates, reacts with all serogroup 1 L. pneumophila strains, including all of the isolates obtained in this study (Table 5) The monoclonal antibody ELISAs, under special circumstances, can be useful epidemiologically. In Indianapolis, most patients with non-nosocomial serogroup 1 L. pneumophila pneumonia have excreted subgroup A antigen in their urine, but patients with nosocomial infections in hospitals 1, 2, and 3 excreted subtype B antigen. For these hospitals, urinary antigen subgrouping is of value in distinguishing nosocomial from non-nosocomial cases as long as the environmental strains do not change.
The data from this study further demonstrate the value of the application of isolate subgrouping to epidemiologic studies of Legionnaires disease (7) . The isolates from the potable water at Indianapolis hospital 1 and from nosocomial cases acquired there between June 1981 and June 1986 (despite intensive efforts to eradicate the organisms) have all been of the Bellingham 1 subgroup, which lends strong support to the hypothesis that these cases were related to ongoing contamination of the potable water with a single established strain of L. pneumophila. A similar correlation was found for hospital 3. Furthermore, the superiority of the subgrouping of isolates with the seven-antibody panel to the subgrouping of urinary antigens with the two-antibody panel is shown in the comparison of nosocomial cases from Indianapolis hospitals 1 and 3. All patients excreted type B antigen, but the patient isolates clearly differed in their subgrouping patterns. Whether a similarly broad antibody panel could be applied as well to urinary antigens as to isolates has not been explored in detail. The possibility of such a typing system is suggested by results from studies by Bibb et al. (1) of two patients, both of whom excreted antigens detected by monoclonal antibody 3 as well as monoclonal antibodies 1 and 2.
In summary, this study demonstrates that the antigen diversity already known to occur among isolates of serogroup 1 L. pneumophila also exists in antigen(s) excreted by these patients. The degree to which the diversity of the urinary antigen epitope mirrors that of the isolates remains to be explored. The urinary antigen diversity will be a complicating factor in the potential use of monoclonal antibodies as replacements for polyclonal antibodies in antigen detection assays. This diversity may, however, increase the value of the assays as epidemiologic tools, particularly if epidemiologic investigations are warranted when patient isolates are few.
